Picture of Acutus Medical logo

AFIB — Acutus Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Late-Breaking Acqforce Flutter Trial Meets Primary Endpoint For Safety And Efficacy With The First Gold-Tipped Contact Force Sensing Ablation Catheter

Feb 6 (Reuters) - Acutus Medical Inc  AFIB.O :
    * LATE-BREAKING ACQFORCE FLUTTER TRIAL MEETS PRIMARY
ENDPOINT FOR
SAFETY AND EFFICACY WITH THE FIRST GOLD-TIPPED CONTACT FORCE
SENSING ABLATION CATHETER
    * ACUTUS MEDICAL INC - ACUTE SUCCESS WAS ACHIEVED IN 94% OF
PATIENTS AND THERE WERE NO SERIOUS ADVERSE EVENTS
    * ACUTUS MEDICAL INC - STUDY DEMONSTRATED COMPARABLE
OUTCOMES TO
HISTORIC CONTROLS WITH SIGNIFICANTLY SHORTER ABLATION TIME AND
LOWER FLUID VOLUMES
    * ACUTUS MEDICAL INC-SUBMITTED PREMARKET APPROVAL
APPLICATION FOR
ACQBLATE FORCE SENSING ABLATION CATHETER, SYSTEM ON OCT 3, 2022,
IS CURRENTLY UNDER REVIEW

Source text for Eikon:  ID:nGNX3qG4Km 
Further company coverage:  AFIB.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Acutus Medical

See all news